IBDEI0VD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15239,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,15240,0)
 ;;=337.20^^81^941^100
 ;;^UTILITY(U,$J,358.3,15240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15240,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,15240,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,15240,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,15241,0)
 ;;=294.8^^81^941^33
 ;;^UTILITY(U,$J,358.3,15241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15241,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,15241,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,15241,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,15242,0)
 ;;=438.6^^81^941^7
 ;;^UTILITY(U,$J,358.3,15242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15242,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,15242,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,15242,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,15243,0)
 ;;=438.7^^81^941^26
 ;;^UTILITY(U,$J,358.3,15243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15243,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,15243,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,15243,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,15244,0)
 ;;=438.84^^81^941^5
 ;;^UTILITY(U,$J,358.3,15244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15244,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,15244,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,15244,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,15245,0)
 ;;=434.91^^81^941^27
 ;;^UTILITY(U,$J,358.3,15245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15245,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,15245,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,15245,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,15246,0)
 ;;=333.94^^81^941^101
 ;;^UTILITY(U,$J,358.3,15246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15246,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,15246,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,15246,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,15247,0)
 ;;=345.90^^81^941^104
 ;;^UTILITY(U,$J,358.3,15247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15247,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,15247,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,15247,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,15248,0)
 ;;=907.0^^81^941^73
 ;;^UTILITY(U,$J,358.3,15248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15248,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,15248,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,15248,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,15249,0)
 ;;=339.00^^81^941^43
 ;;^UTILITY(U,$J,358.3,15249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15249,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,15249,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,15249,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,15250,0)
 ;;=339.01^^81^941^42
 ;;^UTILITY(U,$J,358.3,15250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15250,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,15250,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,15250,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,15251,0)
 ;;=339.02^^81^941^41
 ;;^UTILITY(U,$J,358.3,15251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15251,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,15251,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,15251,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,15252,0)
 ;;=339.03^^81^941^65
 ;;^UTILITY(U,$J,358.3,15252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15252,1,4,0)
 ;;=4^339.03
 ;;^UTILITY(U,$J,358.3,15252,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Episodic
 ;;
 ;;$END ROU IBDEI0VD
